US Patent Issued to The Rockefeller University on Sept. 29 for "Compositions and methods related to human neutralizing antibodies to hepatitis B" (New York Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,283, issued on Sept. 29, was assigned to The Rockefeller University (New York).

"Compositions and methods related to human neutralizing antibodies to hepatitis B" was invented by Qiao Wang (New York) and Michel Nussenzweig (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are broadly neutralizing antibodies (bNAbs) and antigen binding fragments thereof that bind with specificity to epitopes expressed by Hepatitis B vims (HBV). The bNAbs target non-overlapping epitopes on the HBV S antigen (HBsAg). Pharmaceutical compositions that contain the bNAbs, or modified bNAbs, are provided. Combinations of the bNAbs are included, and are usef...